98 filings
Page 2 of 5
8-K
qruu4zlyael3r
6 Aug 19
Dova Pharmaceuticals Reports Second Quarter 2019
7:07am
8-K
l9bco u13uwooim
27 Jun 19
Company Strengthens Thrombocytopenia Portfolio with ITP Approval and Expanded Partnership with Salix for Chronic Liver Disease (CLD) Indication
8:29am
8-K
adeu6b4o
7 May 19
Dova Pharmaceuticals Reports First Quarter 2019 Operating and Financial Results
7:12am
8-K
smy2jxy 6l
26 Apr 19
Submission of Matters to a Vote of Security Holders
4:06pm
DEFA14A
0p1isb43
15 Mar 19
Additional proxy soliciting materials
7:07am
8-K
oxns6h
5 Mar 19
Dova Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Operating and Financial Results
7:11am
8-K
z0dy4a k74fn2
8 Feb 19
Departure of Directors or Certain Officers
5:26pm
8-K
tvv32mz0n 2xjvveq
7 Jan 19
Regulation FD Disclosure
8:58am
8-K
ikt ofp134w
20 Dec 18
Dova Pharmaceuticals Announces Management Changes
10:22am
CT ORDER
wsn7 grunesb0x4co
14 Dec 18
Confidential treatment order
8:57am
8-K
4yx6aejgso8dwtl2sg
8 Nov 18
Dova Pharmaceuticals Reports Third Quarter 2018 Operating and Financial Results
12:00am
8-K
f7caob6u3veova
4 Oct 18
Entry into a Material Definitive Agreement
8:30am
8-K
2g3w6lgexysn1yv
2 Oct 18
Regulation FD Disclosure
8:30am
8-K
lbed0saxogsv6dx09v
27 Sep 18
Entry into a Material Definitive Agreement
12:00am
CT ORDER
o836 h9l0sow2
7 Sep 18
Confidential treatment order
12:00am